Literature DB >> 9028777

Effect of intrathecal serotonin on nociception in rats: influence of the pain test used.

L Bardin1, M Bardin, J Lavarenne, A Eschalier.   

Abstract

The involvement of serotonin (5-HT) in the modulation of nociceptive impulse in the spinal cord has been widely studied. However, its activity, considering the nature of noxious stimuli and the type of 5-HT receptors involved, merits to be further elucidated. The present behavioural study was performed to compare the dose-antinociceptive effect relationship of 5-HT in rats, after intrathecal (i.t.) injection (10 microliters/rat), using mechanical (paw pressure), thermal (tail immersion and tail-flick) and chemical (formalin) pain tests. In rats submitted to the paw pressure test, 5-HT was found to possess a dose-dependent antinociceptive activity (0.01, 0.1, 1, 10 and 20 micrograms/rat) when vocalization threshold was assessed as a pain parameter. A peak effect occurred 5 min after the injection and the effect was maintained for 45 min. The lowest active dose was 0.1 microgram (maximum increase in vocalization thresholds, 23 +/- 3%) and a plateau was observed for 10 micrograms and 20 micrograms (maximum increase in vocalization thresholds, 72 +/- 7% and 71 +/- 6%, respectively). When paw withdrawal was assessed, 5-HT induced a weak hyperalgesic effect for the highest dose (60 micrograms), while other doses were ineffective. In the tail-immersion (warmth and cold) and tail-flick tests, different doses (0.01, 0.1, 1, 10, 30, 60 and 100 micrograms/rat) were studied. In the two immersion tests, only the highest doses (60 micrograms and 100 micrograms) significantly increased the withdrawal thresholds from 5 to 45 min after the injection. The maximum effect was observed at 5 min (23 +/- 4% and 21 +/- 6% for 60 micrograms; 27 +/- 3% and 30 +/- 6% for 100 micrograms in the warmth and cold immersion test, respectively). In the tail-flick test, the doses of 30, 60 and 100 micrograms/rat dose-dependently and significantly increased the withdrawal thresholds from 5 to 45 min after the injection, with a maximum effect at 5 min (30 +/- 5% for 30 micrograms; 37 +/- 6% for 60 micrograms; and 45 +/- 4% for 100 micrograms). In the formalin test, 5-HT (10, 25, 50, 75 and 100 micrograms/rat) produced dose-related antinociception. The nociceptive response (licking of the injected paw) was significantly reduced from 25 micrograms (-59 +/- 11%) in the early phase, whereas the lowest active dose in the late phase was 50 micrograms (-46 +/- 17%). For both phases, a total inhibition was obtained with 100 micrograms. It is concluded that the effect of 5-HT on pain tests may differ according to the applied stimulus and the parameter assessed; unspecific effects of 5-HT may modify motor reactions to noxious stimuli. Mechanical test (assessment of vocalization) was the most sensitive to 5-HT. These observations are of importance in order to further study the pharmacological mechanisms involved in 5-HT spinally induced antinociception.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028777     DOI: 10.1007/bf02454144

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  35 in total

1.  Analgesic profile of centrally administered 2-methylserotonin against acute pain in rats.

Authors:  J Giordano
Journal:  Eur J Pharmacol       Date:  1991-06-25       Impact factor: 4.432

Review 2.  Multiple opioid systems and pain.

Authors:  M J Millan
Journal:  Pain       Date:  1986-12       Impact factor: 6.961

Review 3.  A proposed new nomenclature for 5-HT receptors.

Authors:  P P Humphrey; P Hartig; D Hoyer
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

4.  Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests.

Authors:  Y Kuraishi; N Hirota; M Satoh; H Takagi
Journal:  Brain Res       Date:  1985-02-04       Impact factor: 3.252

5.  The formalin test in mice: effect of formalin concentration.

Authors:  Jan Henrik Rosland; Arne Tjølsen; Bjørn Mæhle; Kjell Hole
Journal:  Pain       Date:  1990-08       Impact factor: 6.961

6.  Modified formalin test: characteristic biphasic pain response.

Authors:  Manabu Shibata; Tsuyako Ohkubo; Hiroshi Takahashi; Reizo Inoki
Journal:  Pain       Date:  1989-09       Impact factor: 6.961

7.  The formalin test in mice: dissociation between inflammatory and non-inflammatory pain.

Authors:  Steinar Hunskaar; Kjell Hole
Journal:  Pain       Date:  1987-07       Impact factor: 6.961

8.  The formalin test: scoring properties of the first and second phases of the pain response in rats.

Authors:  Frances V Abbott; Keith B J Franklin; Frederick R Westbrook
Journal:  Pain       Date:  1995-01       Impact factor: 6.961

Review 9.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

10.  Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord.

Authors:  T Crisp; J L Stafinsky; L J Spanos; M Uram; V C Perni; H B Donepudi
Journal:  Gen Pharmacol       Date:  1991
View more
  16 in total

1.  Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats.

Authors:  T Kamiya; L Wang; P Forsythe; G Goettsche; Y Mao; Y Wang; G Tougas; J Bienenstock
Journal:  Gut       Date:  2005-12-16       Impact factor: 23.059

2.  Pharmacological characterization of serotonin receptor subtypes modulating primary afferent input to deep dorsal horn neurons in the neonatal rat.

Authors:  S M Garraway; S Hochman
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Potentiation of the antinociceptive effect of clomipramine by a 5-ht(1A) antagonist in neuropathic pain in rats.

Authors:  D Ardid; A Alloui; G Brousse; D Jourdan; P Picard; C Dubray; A Eschalier
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

4.  Spinal 5-HT(2) and 5-HT(3) receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats.

Authors:  Rajan Radhakrishnan; Ellen W King; Janelle K Dickman; Carli A Herold; Natalie F Johnston; Megan L Spurgin; Kathleen A Sluka
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

5.  Interaction between midazolam and serotonin in spinally mediated antinociception in rats.

Authors:  T Nishiyama
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

6.  Serotonin concentrations in the lumbosacral spinal cord of the adult rat following microinjection or dorsal surface application.

Authors:  Michele R Brumley; Ian D Hentall; Alberto Pinzon; Brijesh H Kadam; Anthony Blythe; Francisco J Sanchez; Annette M Taberner; Brian R Noga
Journal:  J Neurophysiol       Date:  2007-07-18       Impact factor: 2.714

7.  Different analgesic effects of adenosine between postoperative and neuropathic pain.

Authors:  Gotaro Yamaoka; Hideki Horiuchi; Tadao Morino; Hiromasa Miura; Tadanori Ogata
Journal:  J Orthop Sci       Date:  2012-09-21       Impact factor: 1.601

8.  Adjunctive effect of the serotonin 5-HT2C receptor agonist lorcaserin on opioid-induced antinociception in mice.

Authors:  Salvador Sierra; Kumiko M Lippold; David L Stevens; Justin L Poklis; William L Dewey; Javier González-Maeso
Journal:  Neuropharmacology       Date:  2020-01-24       Impact factor: 5.273

Review 9.  Is serotonin hyperalgesic or analgesic?

Authors:  Claudia Sommer
Journal:  Curr Pain Headache Rep       Date:  2006-04

Review 10.  The development of descending serotonergic modulation of the spinal nociceptive network: a life span perspective.

Authors:  Anne R de Kort; Elbert A J Joosten; Jacob Patijn; Dick Tibboel; Nynke J van den Hoogen
Journal:  Pediatr Res       Date:  2021-07-13       Impact factor: 3.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.